We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
신규 편입 · 포트폴리오 비중 0.05%
신규 편입 · 포트폴리오 비중 0.08%
신규 편입 · 포트폴리오 비중 0.02%
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 05. 14. | After market close (AMC) | $0.24 | — | — | $433.89M | — | Scheduled |
| FY2026 Q3 | 2025. 03. 31. | Time TBD | — | — | — | — | $515.58M | Reported |
| FY2026 Q2 | 2024. 12. 31. | Time TBD | — | — | — | — | $329.35M | Reported |
Consensus PT $55.89 · 9 analysts
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 18. | Morgan Stanley | — | Maintain | Equal-Weight → Equal-Weight | — | Morgan Stanley: Equal-Weight |
| 2026. 05. 16. | Goldman Sachs | — | Maintain | Buy → Buy | — | Goldman Sachs: Buy |
| 2026. 05. 15. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 05. 15. | Oppenheimer | — | Maintain | Outperform → Outperform | — | Oppenheimer: Outperform |
| 2026. 05. 15. | Keybanc | — | Maintain | Overweight → Overweight | — | Keybanc: Overweight |
| 2026. 03. 18. | Oppenheimer | — | Maintain | Outperform → Outperform | — | Oppenheimer: Outperform |